Lu's team will extract immune cells called
T cells from the blood of the enrolled patients, and then use CRISPR — Cas9 technology — which pairs a molecular guide able to identify specific genetic sequences on a chromosome with an enzyme that can snip the chromosome at that spot — to knock out a gene in the cells.
To find out, they studied
T cells from blood samples from 71 children with dengue fever or dengue hemorrhagic fever.
In patients with inflammatory bowel diseases, microbiota - reactive CD4 + T cells were reduced in the blood compared with intestine; T - cell responses that we detected had an increased frequency of interleukin 17A production compared with responses of
T cells from blood or intestinal tissues of controls.
Not exact matches
Consider: Last year alone, the FDA approved two treatments,
from Novartis and Gilead, that literally reengineer patients» immune
T -
cells to target and destroy
blood cancers.
CAR -
T treatments, including competing products
from Novartis rivals Kite Pharma and Juno Therapeutics, come with the risk of potentially deadly side effects such as cytokine - release syndrome (CRS), in which a glut of
T -
cell - assisting cytokines can cause high fever, low
blood pressure, and problems with lung oxygenation.
This new kind of approach to fighting
blood cancers is truly personalized; immune
T -
cells are extracted
from patients, genetically tinkered to home in on an destroy cancerous
cells, multiplied in a lab, and then jolted back into the patient's body within about two weeks.
The quicker
blood flow to the area means the
T cells of the immune system can travel quicker to the muscle, hence the area recovers quicker
from inflammation.
And unlike current flu vaccines, the new version also fuels a strong reaction
from disease - fighting white
blood cells called
T cells.
In
blood samples
from these patients, the researchers found an increase in the percentage of gamma delta
T cells, similar to what they observed in mice, which remained stable over years.
«After already being able to demonstrate the influence of prenatal smoking on regulatory
T -
cell numbers in cord
blood from our LINA study, the current epidemiological investigation delves even deeper into molecular processes,» Dr. Gunda Herberth and Dr. Irina Lehmann resume.
Marta Monteiro and colleagues at the University of Lisbon, Portugal, studied mice protected
from the animal equivalent of multiple sclerosis by natural killer
T -
cells (NKT), a class of white
blood cell which helps to control the immune system.
This drug (vedolizumab) blocks a specific adhesion molecule on the surface of the
T -
cell and thereby inhibits immune
cells from binding themselves to receptors present in the intestine, preventing the
T -
cells from penetrating the
blood vessels in the intestinal tissue.
The temporal association — the number of bacteria increased in the
blood before the SIV appeared in the
blood — led him to believe that the virus first attacks CD4 +
T cells that help protect the gut wall
from microbial translocation.
Researchers are developing many different versions of CAR -
T cell therapies, but the basic premise is the same: Doctors remove a patient's
T cells (immune system
cells that attack invaders)
from a
blood sample and genetically modify them to produce artificial proteins on their surfaces.
By varying the compositions of lipids, cues, and diffusible factors in the scaffolds, we engineered a very versatile and flexible platform that can be used to amplify specific
T cell populations
from blood samples, and that could be deployed in existing therapies such as CAR -
T cell therapies,» said Mooney, Ph.D., a Core Faculty member at the Wyss Institute and leader of its Immunomaterials Platform.
Deletion of the CXCR4 gene led to sustained
T - ALL remission within a month in similar mice, as well as movement of the cancerous
blood cells away
from the bone marrow.
The researchers also analyzed specific immune
cells called cytotoxic
T cells isolated
from the patients»
blood and found increases in biomarkers indicative of immune activation.
But about 20 years ago, researchers started noticing that the levels of cytokines and
T -
cells, which help drive immune responses and secrete cytokines, were higher instead of lower in
blood samples
from people diagnosed with depression.
Next,
T cells — the immune system's foot soldiers — are harvested
from the patient's
blood and infected with the virus, which rewrites their genetic code to recognize and destroy cancer
cells.
Here, Patil et al. have carried out single RNA - seq and sequenced the
T cell receptors (TCRs) of CD4 +
T cells from human
blood to identify precursors that give rise to CD4 - CTLs.
It has been thought that
T cells enter tumors
from the
blood.
«We studied human
T cells, isolated
from blood donors of all ages, to compare mature cytotoxic
T cells with naive ones,» said Philip Ansumana Hull, graduate student in Ott's lab and one of the first authors of the study.
The team used a statistical model of
T cell receptor formation to analyze receptor DNA sequences in
blood samples
from adult pairs of identical twins.
An international team of scientists, led by Monash Biomedicine Discovery Institute researcher Dr Di Yu, and Dr Axel Kallies
from the Walter and Eliza Hall Institute, have discovered that killer
T cells, a specialised type of white
blood cells, can find these «hidden» infected
cells in tissue and destroy them.
«He identified a type of molecular sensor, which programmed
T cells isolated
from human
blood with customized instructions for thwarting attack.
Because the
blood - brain barrier made it impossible for the
T cells to affect the brain
from the inside, Kipnis wondered whether they were maximizing their long - distance influence by getting as close as they could to the brain.
The scientists drew
blood from old mice, whose supply of
T cells was depleted, and isolated immune
cells.
Her research suggested that
T cells can also send signals that activate the brain's resident immune
cells, microglia and
blood - borne macrophages, telling them to protect the injured neurons
from toxins released by the injury.
T cells are collected
from the patient's
blood and genetically engineered to express
cell - surface proteins called CARs, which recognize specific molecules found on the surface of cancer
cells.
Because CD4 + (helper)
T cell responses have been shown to be sufficient for protection
from WNV challenge (independent of B
cells and CD8 +
T cells) and crucial for viral clearance
from the CNS, the researchers focused on the WNV - specific CD4 +
T cell repertoires present in the
blood samples.
Scientists have long thought that HIV infects only memory
T cells, based on studies of
T cells isolated
from blood.
Using a new method, the scientists therefore isolated
T cells specifically programmed to target the CMV virus
from the
blood of the donor and transferred small numbers of these
cells to the patients.
The immune system protects us
from scores of invaders, but it can also turn against us when white
blood cells called autoimmune
T cells attack the body's own tissue.
Instead of responding to viruses or other foreign invaders in the body, the activated CD8 +
T cells launch an inflammatory response to fat, and to bacterial components that migrate to the liver
from the gut through the
blood.
Using
cells from mice and human livers, Toronto General Hospital Research Institute researchers demonstrated for the first time how under specific conditions, such as obesity, liver CD8 +
T cells, white
blood cells which play an important role in the control of viral infections, become highly activated and inflammatory, reprogramming themselves into disease - driving
cells.
T cells, which circulate in the
blood, are an obvious candidate for medical applications of the technology, as these
cells not only stand at the center of many disease processes, but could be easily gathered
from patients, edited with CRISPR / Cas9, then returned to the body to exert therapeutic effects.
In further investigations of human liver
cells from nearly 50 donor tissues of humans with varying degrees of body mass index (BMI) and liver fat, higher levels of CD8 +
T cells were linked with higher levels of
blood sugar or more advanced fatty liver disease.
The trial participants had
T cells removed
from their
blood and then modified in the laboratory with a designer enzyme engineered by Sangamo BioSciences in Richmond, California.
Whole
blood from rhesus macaques (Macaca mulatta) housed at the Tulane National Primate Research Center was used for CD4 +
T cell isolation and ZFN treatment.
Gaddis found regulatory
T cells in the aorta — the large artery that carries
blood from the heart to the rest of the body — in all of the mice.
These CARs contain two fused parts: an antibody that protrudes
from the surface of a
T -
cell to recognise a protein on cancerous B -
cells (commonly CD - 19) in the
blood and a receptor inside the
T -
cell that sends messages to cellular machinery.
HAT sensitive derivative of CEM, a human
T -
cell line derived
from the peripheral
blood buffy coat of a four - year old Caucasian female with acute lymphoblastic leaukemia.
Although similar numbers of total splenic gp33 - LCMV — specific
T cells were observed between genotypes (Fig. 5B), the distribution of gp33 - LCMV — specific CD8 +
T cell effector and memory subsets were altered, such that there was a significantly lower percentage of short - term effector
T cells and reciprocal changes in memory precursor
cells among gp33 - specifc CD8 +
T cells in WT relative to DKO mice (Fig. 5C), with a trend in changes in absolute
cell numbers, consistent with temporal data
from peripheral
blood (Fig. 5A).
We have also generated
T - regs (CD4 + / 25high / 127low / --RRB- in vitro
from donor AD - MSC and recipient peripheral
blood mononuclear
cells and these
T - regs are infused in thymus of renal allograft recipients after kidney transplantation.
One other potentially interesting finding
from the Protocol C cohort is the identification of higher levels of memory
T follicular helper (Tfh)
cells in the
blood,
cells that have both transcriptional and functional properties.
Mesenchymal stromal
cells promote or suppress the proliferation of
T lymphocytes
from cord
blood and peripheral
blood: the importance of low
cell ratio and role of interleukin - 6.
In late 2015, the company also launched its MagCloudz streptavidin
cell - separation kit and partnered with the University of Massachusetts Medical School in research toward the enrichment and purification of CD3 +
T cells from human umbilical cord
blood.
Endogenous
T cell therapy utilizes naturally - occurring antigen - specific
T cells isolated
from peripheral
blood to treat solid tumor malignancies.
a Cellular composition analysis for 18
cell types shows an increase in NK -
cells - resting and
T -
cells - CD8 and decrease in Neutrophils composition
from pre - to post-mortem
blood samples.
After infusion, the signal
from the genetically modified
T cells in the peripheral
blood increased up to 100-fold and the DNRII - LSTs persisted for up to 4 years, according to the authors.